Alabama’s New Rule Has Massive DSCSA Implications on State Regulations Sumeet Singh, Founder & Chairman, Pharma Solutions In 2013, the United States Congress passed the Drug Supply Chain Security Act (DSCSA) with the aim of safeguarding patients against the...
NABP DDA: New Process & “Ineligibility Matrix” The National Association of Boards of Pharmacy® (NABP®) has posted on their website and has sent...
In recent months, the reversals on policy regarding awarding extensions to the highly controversial PBM requirement has caused a lot of confusion....
New Version of the NABP DDA P&P Assessment Released NABP has released a new version of its Policy and Procedure Assessment for Drug Distributor...
Optum Rx’s requirement for their network pharmacies to only purchase prescription drug and diabetic testing supplies from Accredited wholesalers has caused significant disruption and controversy since its implementation in August 2016. The requirement spurred two separate lawsuits. The second, which continues in full force, has a recent amended complaint – and Pharma Solutions has unique insight into the lawsuit’s developments.
OptumRx Network Policy: VAWD Requirement for Manufacturers and VDIP Accreditation By now, OptumRx’s VAWD Accreditation requirement has become a...
Teva Pharmaceuticals Earns VAWD Reaccreditation! We are excited to announce that our client, Teva Pharmaceuticals, was awarded VAWD® Reaccreditation...
